Skip to main content
. Author manuscript; available in PMC: 2020 Nov 3.
Published in final edited form as: Hum Genet. 2019 Feb 18;138(3):231–239. doi: 10.1007/s00439-019-01980-3

Figure 3:

Figure 3:

tRNAVal(AAC) purified from LCLs of patients with the PUS7.Asp503Tyr mutation have reduced Ψ relative to that from control LCLs. LCLs were grown and tRNA was purified and analyzed for modifications as described in Materials and Methods. Data derives from Table 1, showing that Ψ levels are reduced in patient LCLs (by 0.88 mole/mole), whereas levels of each of two other modifications are not.